2011年9月23日－2011年9月28日第36届ESMO（the European Society for Medical Oncology）在瑞典斯德哥尔摩举行，此次会议规模空前未有。罗氏,作为在肿瘤诊断和治疗领域研究、开发的领导者，积极参与了本次学术盛会。
|
演讲主题：
|
|
| The importance of EGFR mutation status in guiding first-line treatments | Griesinger |
| Anti-angiogenic therapy in NSCLC:real-life perspectives | Wolf |
| Advanced Non-Small Cell Lung Cancer:Clinical Trials to Clinical Pracetice | Ettinger |
| New milestones in first-line trearment of adenocarinoma NSCLC | Barlesi |
| Navigating the options for post-platinum treatment | Perol |
| Looking to the future: new treatment approaches | Stahel |
| AVAPERL (MO22089) | F.Barlesi |
| Biomarker analysis in BO21015 (ABIGAIL) | TonyMok |
